Ares Capital (ARCC) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Werte in diesem Artikel
In its upcoming report, Ares Capital (ARCC) is predicted by Wall Street analysts to post quarterly earnings of $0.57 per share, reflecting a decline of 9.5% compared to the same period last year. Revenues are forecasted to be $784.96 million, representing a year-over-year increase of 11%.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.Bearing this in mind, let's now explore the average estimates of specific Ares Capital metrics that are commonly monitored and projected by Wall Street analysts.The average prediction of analysts places 'Dividend income' at $146.30 million. The estimate compares to the year-ago value of $129 million.Based on the collective assessment of analysts, 'Other Income' should arrive at $17.11 million. Compared to the present estimate, the company reported $16 million in the same quarter last year.The consensus estimate for 'Capital Structuring Service Fees' stands at $43.34 million. Compared to the present estimate, the company reported $41 million in the same quarter last year.The combined assessment of analysts suggests that 'Interest Income From Investments' will likely reach $579.34 million. Compared to the present estimate, the company reported $521 million in the same quarter last year.View all Key Company Metrics for Ares Capital here>>>Over the past month, Ares Capital shares have recorded returns of +6.7% versus the Zacks S&P 500 composite's +2.7% change. Based on its Zacks Rank #2 (Buy), ARCC will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ares Capital Corporation (ARCC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Ares Capital
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ares Capital
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Ares Capital CorpShs
Analysen zu Ares Capital CorpShs
Datum | Rating | Analyst | |
---|---|---|---|
23.08.2019 | Ares Capital Neutral | Compass Point | |
19.08.2019 | Ares Capital Outperform | BMO Capital Markets | |
21.09.2017 | Ares Capital Outperform | Oppenheimer & Co. Inc. | |
28.06.2016 | Ares Capital Neutral | National Securities | |
25.02.2016 | Ares Capital Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
19.08.2019 | Ares Capital Outperform | BMO Capital Markets | |
21.09.2017 | Ares Capital Outperform | Oppenheimer & Co. Inc. | |
25.02.2016 | Ares Capital Overweight | Barclays Capital | |
30.09.2015 | Ares Capital Buy | D.A. Davidson & Co. | |
13.02.2015 | Ares Capital Market Perform | BMO Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
23.08.2019 | Ares Capital Neutral | Compass Point | |
28.06.2016 | Ares Capital Neutral | National Securities | |
05.05.2015 | Ares Capital Hold | BB&T Capital Markets | |
20.08.2009 | Allied Capital market perform | Keefe, Bruyette & Woods, Inc. | |
06.02.2007 | Update Allied Capital Corp.: Hold | AG Edwards |
Datum | Rating | Analyst | |
---|---|---|---|
06.12.2005 | Update Allied Capital Corp.: Underperform | Harris Nesbitt |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ares Capital CorpShs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen